Bei Wang Email
Director QA and QC @ POINT Biopharma
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Bei Wang Location
- Canada
Bei Wang Work
- Director QA and QC @ (March 2024 - Present)
- Director QA and QC @ UHN / POINT Biopharma (September 2022 - March 2024)
- Quality Assurance Manager @ (January 2022 - September 2022)
- Quality Assurance Supervisor @ (January 2020 - January 2021)
- Supervisor QA of QC @ (January 2018 - January 2019)
- QA and QC Compliance Specialist @ (January 2015 - January 2018)
- Senior Analyst @ (January 2013 - January 2015)
- Scientist @ (January 2011 - January 2012)
- Scientist @ Eli Lilly Canada (January 2000 - January 2011)
Bei Wang Education
- University of Waterloo 1995-2000
Bei Wang Skills
- Pharmaceutical Industry
- HPLC
- Pharmacovigilance
- GLP
- Sop
- CAPA
- Analytical Chemistry
- Validation
- GMP
- Quality Assurance
- qulity audit
- Technical Writing
- Risk Assessment
- Risk Management
Bei Wang Summary
- Bei Wang, based in Canada, is currently a Director QA and QC at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company. Bei Wang brings experience from previous roles at UHN / POINT Biopharma, ANI Pharmaceuticals, Inc. and Taro Pharmaceuticals. Bei Wang holds a 1995 - 2000 University of Waterloo. With a robust skill set that includes Pharmaceutical Industry, HPLC, Pharmacovigilance, GLP, Sop and more. Bei Wang has 1 emails on RocketReach.
Looking for a different Bei Wang?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co